{"transactions":[{"id":856464,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T23:15:53.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":4986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":4986,"derivative":{"exercise_price":434.8,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":4986},"source":{"system":"sec-edgar","filing":"0001628280-26-015758","document":"wk-form4_1772838950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015758/wk-form4_1772838950.xml","form_type":"4"}},{"id":856463,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T23:15:53.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":419,"price":431.94,"value":180982.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":12692,"source":{"system":"sec-edgar","filing":"0001628280-26-015758","document":"wk-form4_1772838950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015758/wk-form4_1772838950.xml","form_type":"4"}},{"id":856462,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T23:15:53.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":3989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":13111,"source":{"system":"sec-edgar","filing":"0001628280-26-015758","document":"wk-form4_1772838950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015758/wk-form4_1772838950.xml","form_type":"4"}},{"id":931346,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-26T22:38:40.000Z","date":"2026-01-26","kind":"sale","planned":true,"acquired":false,"shares":570,"price":494.59,"value":281916.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."}],"balance_after":9122,"source":{"system":"sec-edgar","filing":"0001628280-26-003482","document":"wk-form4_1769467117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026003482/wk-form4_1769467117.xml","form_type":"4"}},{"id":931345,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-26T22:38:40.000Z","date":"2026-01-26","kind":"sale","planned":true,"acquired":false,"shares":340,"price":492.42,"value":167422.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":9692,"source":{"system":"sec-edgar","filing":"0001628280-26-003482","document":"wk-form4_1769467117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026003482/wk-form4_1769467117.xml","form_type":"4"}},{"id":991647,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":80,"price":564.565,"value":45165.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.55 to $564.58, inclusive."}],"balance_after":10032,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991646,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":40,"price":563.21,"value":22528.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."}],"balance_after":10112,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991645,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":80,"price":560.62,"value":44849.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $560.24 to $561.00, inclusive."}],"balance_after":10152,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991644,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":200,"price":559.598,"value":111919.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $559.22 to $560.06, inclusive."}],"balance_after":10232,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991643,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":120,"price":556.04,"value":66724.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.74 to $556.19, inclusive."}],"balance_after":10432,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991642,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":40,"price":553.2283,"value":22129.132,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.22 to $553.23, inclusive."}],"balance_after":10552,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991641,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":200,"price":552.384,"value":110476.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.96 to $552.81, inclusive."}],"balance_after":10592,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991640,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":40,"price":549.3425,"value":21973.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.30 to $549.38, inclusive."}],"balance_after":10792,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991639,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":120,"price":548.71,"value":65845.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.25 to $548.94, inclusive."}],"balance_after":10832,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991638,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":144,"price":547.2683,"value":78806.6352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.12 to $547.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":10952,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":991637,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-21T22:39:36.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":894,"price":550.97,"value":492567.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":11096,"source":{"system":"sec-edgar","filing":"0001628280-25-053648","document":"wk-form4_1763764773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/wk-form4_1763764773.xml","form_type":"4"}},{"id":1217900,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-07T21:31:44.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (March 5, 2026) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":5703,"derivative":{"exercise_price":347.28,"expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":5703},"source":{"system":"sec-edgar","filing":"0001628280-25-011321","document":"wk-form4_1741383098.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025011321/wk-form4_1741383098.xml","form_type":"4"}},{"id":1217899,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-07T21:31:44.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":3386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 5, 2026, March 5, 2027, March 5, 2028 and March 5, 2029, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":11990,"source":{"system":"sec-edgar","filing":"0001628280-25-011321","document":"wk-form4_1741383098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025011321/wk-form4_1741383098.xml","form_type":"4"}},{"id":1223439,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":563,"price":335,"value":188605.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."}],"balance_after":8604,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1223438,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":329.64,"value":32964.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."}],"balance_after":9167,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1223437,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":327.49,"value":32749.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."}],"balance_after":9267,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1223436,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":326.34,"value":32634.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."}],"balance_after":9367,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1223435,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":200,"price":324.59,"value":64918.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.48 to $324.70, inclusive."}],"balance_after":9467,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1223434,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":200,"price":323.65,"value":64730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.47 to $323.83, inclusive."}],"balance_after":9667,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1223433,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":300,"price":320.21,"value":96063.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.13 to $320.32, inclusive."}],"balance_after":9867,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1223432,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":200,"price":314.74,"value":62948.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.40 to $315.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below."}],"balance_after":10167,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1223431,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:24:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":71,"price":313.08,"value":22228.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024."}],"balance_after":10367,"source":{"system":"sec-edgar","filing":"0001628280-25-010492","document":"wk-form4_1741209863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010492/wk-form4_1741209863.xml","form_type":"4"}},{"id":1294658,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-27T22:18:36.000Z","date":"2025-01-24","kind":"sale","planned":false,"acquired":false,"shares":347,"price":335.24,"value":116328.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":10438,"source":{"system":"sec-edgar","filing":"0001628280-25-002680","document":"wk-form4_1738016309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025002680/wk-form4_1738016309.xml","form_type":"4"}},{"id":1354832,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-22T21:30:09.000Z","date":"2024-11-21","kind":"sale","planned":false,"acquired":false,"shares":688,"price":316.92,"value":218040.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":10785,"source":{"system":"sec-edgar","filing":"0000950170-24-130239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024130239/ownership.xml","form_type":"4"}},{"id":1671179,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Market Stock Unit","published_at":"2024-01-25T23:04:23.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":3639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each market stock unit, which is performance-based, represents the contingent right to receive one share of common stock. The amount reported represents the target number of shares which may be issued upon vesting. The market stock units will vest upon certification concerning the Company's stock price performance measured against biotechnology stock index companies for the entire performance period ending December 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each market stock unit, which is performance-based, represents the contingent right to receive one share of common stock. The amount reported represents the target number of shares which may be issued upon vesting. The market stock units will vest upon certification concerning the Company's stock price performance measured against biotechnology stock index companies for the entire performance period ending December 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each market stock unit, which is performance-based, represents the contingent right to receive one share of common stock. The amount reported represents the target number of shares which may be issued upon vesting. The market stock units will vest upon certification concerning the Company's stock price performance measured against biotechnology stock index companies for the entire performance period ending December 31, 2026."}],"balance_after":3639,"derivative":{"underlying":"Common Stock","underlying_shares":3639},"source":{"system":"sec-edgar","filing":"0000950170-24-007572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024007572/ownership.xml","form_type":"4"}},{"id":1671178,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T23:04:23.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":5483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (January 23, 2025) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":5483,"derivative":{"exercise_price":229,"expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":5483},"source":{"system":"sec-edgar","filing":"0000950170-24-007572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024007572/ownership.xml","form_type":"4"}},{"id":1671177,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-25T23:04:23.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":3639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of January 23, 2025, January 23, 2026, January 23, 2027 and January 23, 2028, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":11473,"source":{"system":"sec-edgar","filing":"0000950170-24-007572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024007572/ownership.xml","form_type":"4"}},{"id":1731594,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:02:08.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":10077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (November 20, 2024) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":10077,"derivative":{"exercise_price":190.05,"expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":10077},"source":{"system":"sec-edgar","filing":"0000950170-23-065902","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023065902/ownership.xml","form_type":"4"}},{"id":1731593,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":62345,"kind":"person","name":"Huntsman Carole","position":1,"cik":"0002001571","reported_name":"Huntsman Carole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-11-22T22:02:08.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":7834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of November 20, 2024, November 20, 2025, November 20, 2026 and November 20, 2027, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":7834,"source":{"system":"sec-edgar","filing":"0000950170-23-065902","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017023065902/ownership.xml","form_type":"4"}}]}